{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T16:45:36Z","timestamp":1648572336635},"reference-count":15,"publisher":"Walter de Gruyter GmbH","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Pheochromocytoma is a rare adrenal gland tumor that is often difficult for physicians to diagnose because of its general, nonspecific complaints. Diagnosis is particularly difficult in patients with neurofibromatosis 1, because pheochromocytoma in these patients will mimic other cardiovascular abnormalities. The authors report the case of a 60-year-old woman with an extensive history of hyperlipidemia, malignant hypertension, coronary artery disease, and neurofibromatosis 1 who was referred for an elective cardiac catheterization as a result of an abnormal stress test. The patient returned to the hospital 3 days after the procedure complaining of increased angina and palpitations. While hospitalized, she developed severe episodic hypertension. A computed tomographic scan revealed bilateral adrenal masses. Findings of biochemical and imaging evaluation confirmed the diagnosis of bilateral pheochromocytoma. Early screening of pheochromocytomas in high-risk populations is essential for prompt diagnosis and successful management.<\/jats:p>","DOI":"10.7556\/jaoa.2015.092","type":"journal-article","created":{"date-parts":[[2015,6,25]],"date-time":"2015-06-25T16:31:28Z","timestamp":1435249888000},"page":"e3-e7","source":"Crossref","is-referenced-by-count":1,"title":["Pheochromocytoma Diagnosis After an Abnormal Stress Test: Case Report and Review of the Literature"],"prefix":"10.1515","volume":"115","author":[{"given":"German","family":"Treyger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn A.","family":"Silver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alla A.","family":"Sakharova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2015,7,1]]},"reference":[{"issue":"4","key":"2022022616261354409_j_jaoa.2015.092_ref_001","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1210\/er.2002-0013","article-title":"Pheochromocytoma: state-of-the-art and future prospects","volume":"24","author":"Bravo","year":"2003","journal-title":"Endocr Rev"},{"issue":"1","key":"2022022616261354409_j_jaoa.2015.092_ref_002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2008.12.051","article-title":"Neurofibromatosis type 1","volume":"61","author":"Boyd","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"9486","key":"2022022616261354409_j_jaoa.2015.092_ref_003","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","author":"Lenders","year":"2005","journal-title":"Lancet"},{"issue":"9","key":"2022022616261354409_j_jaoa.2015.092_ref_004","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/00003072-199609000-00005","article-title":"Location of adrenal medullary pheochromocytoma by I-123 metaiodobenzylguanidine SPECT","volume":"21","author":"Nielsen","year":"1996","journal-title":"Clin Nucl Med"},{"issue":"7","key":"2022022616261354409_j_jaoa.2015.092_ref_005","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1634\/theoncologist.2008-0043","article-title":"Pheochromocytoma: current approaches and future directions [published online July 10, 2008]","volume":"13","author":"Adler","year":"2008","journal-title":"Oncologist"},{"issue":"5","key":"2022022616261354409_j_jaoa.2015.092_ref_006","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/ajmg.a.35829","article-title":"Persistent hypertension despite successful dilation of a stenotic renal artery in a boy with neurofibromatosis type 1 [published online April 5, 2013]","volume":"161A","author":"Ueda","year":"2013","journal-title":"Am J Med Genet A"},{"issue":"4","key":"2022022616261354409_j_jaoa.2015.092_ref_007","doi-asserted-by":"crossref","first-page":"315","DOI":"10.7326\/0003-4819-134-4-200102200-00016","article-title":"Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma","volume":"134","author":"Pacak","year":"2001","journal-title":"Ann Intern Med"},{"issue":"5","key":"2022022616261354409_j_jaoa.2015.092_ref_008","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/RCT.0b013e31829cbecf","article-title":"Serendipity in the diagnosis of pheochromocytoma","volume":"37","author":"Oshmyansky","year":"2013","journal-title":"J Comput Assist Tomogr"},{"issue":"6","key":"2022022616261354409_j_jaoa.2015.092_ref_009","first-page":"354","article-title":"Prevalence of clinically unsuspected pheochromocytoma: review of a 50-year autopsy series","volume":"56","author":"Sutton","year":"1981","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"2022022616261354409_j_jaoa.2015.092_ref_010","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.5858\/2008-132-1272-PAEPU","article-title":"Pheochromocytoma and extra-adrenal paraganglioma: updates","volume":"132","author":"Tischler","year":"2008","journal-title":"Arch Pathol Lab Med"},{"issue":"16","key":"2022022616261354409_j_jaoa.2015.092_ref_011","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/jnci\/djg024","article-title":"Nathanson KL. Pheochromocytoma: the expanding genetic differential diagnosis","volume":"95","author":"Bryant","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"2022022616261354409_j_jaoa.2015.092_ref_012","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-7819-8-14","article-title":"Pheochromocytoma associated with neurofibromatosis type 1: concepts and current trends","volume":"8","author":"Zografos","year":"2010","journal-title":"World J Surg Oncol"},{"key":"2022022616261354409_j_jaoa.2015.092_ref_013","article-title":"National Cancer Institute at the National Institute of Health website"},{"issue":"2","key":"2022022616261354409_j_jaoa.2015.092_ref_014","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ncpendmet0396","article-title":"Pheochromocytoma: recommendations for clinical practice from the first international symposium: October 2005","volume":"3","author":"Pacak","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2022022616261354409_j_jaoa.2015.092_ref_015","volume-title":"Greenspan's Basic and Clinical Endocrinology","author":"Gardner","year":"2011","edition":"9th ed."}],"container-title":["Journal of Osteopathic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.7556\/jaoa.2015.092\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.7556\/jaoa.2015.092\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T16:26:38Z","timestamp":1645892798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.7556\/jaoa.2015.092\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,1]]},"references-count":15,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,1]]},"published-print":{"date-parts":[[2015,7,1]]}},"alternative-id":["10.7556\/jaoa.2015.092"],"URL":"https:\/\/doi.org\/10.7556\/jaoa.2015.092","relation":{},"ISSN":["2702-3648"],"issn-type":[{"value":"2702-3648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,1]]}}}